GGrantIndex
← Leaderboards

Areej El-Jawahri

Massachusetts General Hospital

$7,087,400
Attributed
$9,249,929
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY201825
$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,249,929 · 8

By mechanism

R01$8,283,885 · 6
R21$966,044 · 2

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Randomized Trial

Research focus

Randomized TrialEnsureEnvironmentPalliative CareCaringSiteRandomizedHospitalizationPatient PopulationInfrastructureQuality Of LifeTrainingMassachusettsFoundationsReportingGeneral HospitalsInnovationDepressive SymptomsAnxiety SymptomsPsychological DistressCommunicationPatient-Focused OutcomesTreatment As UsualLife

Grant awards (21)

Randomized Trial of a Multi-Disciplinary Intervention for Patients with Chronic Grant-Versus-Host Disease$599,339
R01 · FY2025 · CA
BMT-CARE: Multimodal Psychosocial Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation$597,156
R01 · FY2025 · CA · contact PI
Title: Multi-Site Randomized Controlled Trial of a Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors$583,190
R01 · FY2025 · CA · contact PI
Multi-Site Randomized Controlled Trial of a Novel Digital Application (DREAMLAND) to Improve Outcomes for Patients with Acute Myeloid Leukemia$565,763
R01 · FY2025 · CA · contact PI
BMT-CARE: Multimodal Psychosocial Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation$619,062
R01 · FY2024 · CA · contact PI
Title: Multi-Site Randomized Controlled Trial of a Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors$602,526
R01 · FY2024 · CA · contact PI
Multi-Site Randomized Controlled Trial of a Novel Digital Application (DREAMLAND) to Improve Outcomes for Patients with Acute Myeloid Leukemia$591,372
R01 · FY2024 · CA · contact PI
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness$388,444
R01 · FY2024 · NR · contact PI
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness$376,547
R01 · FY2023 · NR · contact PI
Examining Gender as a Sociocultural Variable Shaping Health Outcomes of Cancer Caregiving$165,574
R21 · FY2023 · CA
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation$438,365
R01 · FY2022 · CA · contact PI
Building Resiliency Among Caregivers of Curvivors and Metavivors: A Pilot randomized Trial$431,970
R21 · FY2022 · CA
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness$373,494
R01 · FY2022 · NR · contact PI
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation$444,087
R01 · FY2021 · CA · contact PI
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness$373,494
R01 · FY2021 · NR · contact PI
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation$440,257
R01 · FY2020 · CA · contact PI
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness$399,979
R01 · FY2020 · NR · contact PI
Multimodal Mobile Intervention Application (app) to Address Symptoms in Hematopoietic Stem Cell Transplant Survivors$167,500
R21 · FY2020 · NR · contact PI
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation$430,748
R01 · FY2019 · CA · contact PI
Multimodal Mobile Intervention Application (app) to Address Symptoms in Hematopoietic Stem Cell Transplant Survivors$201,000
R21 · FY2019 · NR · contact PI
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation$460,062
R01 · FY2018 · CA · contact PI